ST. PAUL, Minn., May 14, 2025 - In a significant boost to cell and gene therapy research, ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady, has awarded three G-Rex Grants totaling $1,025,000 to faculty members at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA). These grants aim to support the translation of various cell and gene therapy initiatives into clinical applications. Notable recipients include Dr. Mohamed Abou-el-Enein, who secured $300,000 to advance a novel non-viral CAR-T cell therapy manufacturing platform, and Dr. Shahab Asgharzadeh, who received $250,000 for preclinical development of a new CAR-T cell therapy for solid tumors. Dr. Preet Chaudhary was awarded $200,000 for synthetic immune receptor engineered T cell therapy process development. The funding is set to enhance CAR-T manufacturing and contribute to cutting-edge therapeutic solutions.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。